88IV - PR Newswire Asia's news - Medical/Pharmaceuticals

< Previous page

| Title only | Print

Next page >

First Patients Dosed in OPTIMAL-e Trial for Earlier Stage Prostate Cancer First patients dosed in OPTIMAL-e [1] Phase 2 study evaluating TLX597-Tx for metastatic hormone-sensitive prostate cancer at St Vincent's Hospital Sydney. OPTIMAL-e will evaluate TLX597-Tx in earlier ... 2026-07-16T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
China Pharma Holdings, Inc. States It Knows of No Events That Could Have Caused Unusual Market Activity HAIKOU, China , July 16, 2026 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI) ("China Pharma" or the "Company"), a fully-integrated specialty pharmaceuticals ... 2026-07-16T Banking/Financial Service Health Care/Hospital Medical/Pharmaceuticals
Metabolon Expands Microbiome Panel to Strengthen Industry Leadership in Functional Microbiome Research Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health, nutrition, disease, and treatment response ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Seegene: "Virus-Only Testing May Miss Pneumonia-associated Bacterial Respiratory Pathogens" Calls for a Shift to Comprehensive Syndromic PCR Testing Virus-only testing may miss pneumonia-associated bacterial co-detections in 78% of virus-positive cases, while bacteria-only testing may miss viral co-detections in 88% of cases positive for pneumonia-associated ... 2026-07-15T Health Care/Hospital Infectious Disease Control Medical/Pharmaceuticals
Bambusa Therapeutics Appoints Howard Liang, Ph.D. to its Board of Directors and Establishes Scientific Advisory Board Dr. Liang brings deep biopharma finance, strategy, and capital markets expertise to support the company's next phase of growth ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ractigen Therapeutics Announces Landmark Publication in Nature Medicine Highlighting Unprecedented Preclinical Efficacy and Positive First-in-Human Clinical Data for RAG-17 in SOD1-ALS — Peer-reviewed publication details RAG-17's robust translation from "bench to bedside," validating the proprietary SCAD™ delivery platform for CNS-targeted RNAi therapies — ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
POMDOCTOR LIMITED Advances Healthcare Data Asset Strategy to Strengthen AI-Powered Chronic Disease Management Capabilities GUANGZHOU, China , July 15, 2026 /PRNewswire/ -- POMDOCTOR LIMITED ("Pomdoctor" or the "Company") (NASDAQ: POM), a digital healthcare company focused on advancing AI-enabled ... 2026-07-15T Health Care/Hospital Medical Equipment Medical/Pharmaceuticals
Septa Pharmaceuticals Inc. Acquires CeeNU® (Lomustine) from Bristol Myers Squibb, Canada MISSISSAUGA, ON, July 15, 2026 /PRNewswire/ -- Septa Pharmaceuticals Inc. , a rapidly growing leader in the Canadian healthcare sector, is proud to announce the successful acquisition of CeeNU ® ... 2026-07-15T Health Care/Hospital Medical/Pharmaceuticals
Harbour BioMed and Kelun-Biotech Announce NMPA Approval of IND Application for HBM7575/SKB575 for the Treatment of Asthma CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , July 15, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Ascletis Selects for Clinical Development a Fixed-Dose Combination of First-in-Class Oral Small Molecule GIPR Agonist, ASC48, and Oral Small Molecule GLP-1R Agonist, ASC30 - ASC48 is a potentially first-in-class oral small molecule GIPR agonist. ... 2026-07-15T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2026

Suntek Computer Systems Limited.

All rights reserved